Global race for better kidney cancer treatment

NCT ID NCT07000149

Summary

This large global study is testing two new drug combinations for advanced kidney cancer that has spread. Researchers are comparing these new treatments against the current standard treatment to see which works better at controlling the cancer and helping patients live longer. The trial involves over 1,100 patients who haven't received any previous treatment for their advanced kidney cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CLEAR CELL RENAL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    La Jolla, California, 92037, United States

  • Research Site

    Aurora, Colorado, 80045, United States

  • Research Site

    Boston, Massachusetts, 02215, United States

  • Research Site

    New York, New York, 10065, United States

  • Research Site

    Cleveland, Ohio, 44106, United States

  • Research Site

    Nashville, Tennessee, 37232, United States

  • Research Site

    Lubbock, Texas, 79430, United States

  • Research Site

    East Melbourne, 3002, Australia

  • Research Site

    Elizabeth Vale, 5112, Australia

  • Research Site

    North Adelaide, 5000, Australia

  • Research Site

    Syndey, 4032, Australia

  • Research Site

    Beijing, 100142, China

  • Research Site

    Guangzhou, 510060, China

  • Research Site

    Nanjing, 2100008, China

  • Research Site

    Nanning, 530021, China

  • Research Site

    Shanghai, 200032, China

  • Research Site

    Xiamen, 361003, China

  • Research Site

    Batumi, 6010, Georgia

  • Research Site

    Tbilisi, 0112, Georgia

  • Research Site

    Tbilisi, 0114, Georgia

  • Research Site

    Tbilisi, 0186, Georgia

  • Research Site

    Busan, 48108, South Korea

  • Research Site

    Seongnam-si, 13496, South Korea

  • Research Site

    Seongnam-si, 13620, South Korea

  • Research Site

    Seoul, 03080, South Korea

  • Research Site

    Seoul, 03722, South Korea

  • Research Site

    Seoul, 06591, South Korea

  • Research Site

    Seoul, 5505, South Korea

  • Research Site

    Kaohsiung City, 833401, Taiwan

  • Research Site

    Taichung, 404327, Taiwan

  • Research Site

    Taichung, 40705, Taiwan

  • Research Site

    Tainan, 704, Taiwan

Conditions

Explore the condition pages connected to this study.